In MDS/AML-related CH, spliceosome components (SF3B1/SRSF2/U2AF1) can be frequently mutated as early mutations in AML and MDS derived from CHIP or CCUS [26]. The gene discussed is U2AF1; the disease is myelodysplastic syndrome.